课题基金 / 基金详情

Task X19: Development of Assays and Reagents for Zika Virus Vaccines

Task X19: Development of Assays and Reagents for Zika Virus Vaccines
任务 X19：寨卡病毒疫苗检测方法和试剂的开发
批准号：
10169160
负责人：
RANDI HORNBACK
金额：
$5.54万
依托单位：
BATTELLE CENTERS/PUB HLTH RES & EVALUATN
依托单位国家：
美国
项目类别：
财政年份：
2016
资助国家：
美国
项目状态：
已结题
起止时间：
2016-08-31 至 2021-05-31
来源：
https://reporter.nih.gov/project-details/10169160
关键词：
BiologicalClinicalCommunicable DiseasesContractsDevelopmentFeasibility StudiesPhaseReagentSamplingServicesTestingToxicity TestsVaccinesZika virus vaccineassay developmentefficacy testingevaluation/testingimmunogenicitynovel vaccinesproduct developmentsafety testingtesting services

项目摘要

项目成果

RANDI HORNBACK的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The Evaluation and Testing Services (ETS) for Vaccines and Other Biologics for Infectious Diseases contract provides a variety of product development services from early feasibility studies through manufacture of Phase I/II material, including assay development; immunogenicity and efficacy testing; clinical and nonclinical sample testing; and safety and toxicity testing. These services will facilitate the development and introduction of new vaccines and biologics against a wide array of infectious diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
TASK X25: Preparedness for Testing NIAID Priority Vaccines in Neurovirulence and Reproductive Toxicology Studies
Task X21: Preparedness for Testing NIAID Priority Vaccines in General Safety and Toxicology Studies
TASK X25: Preparedness for Testing NIAID Priority Vaccines in Neurovirulence and Reproductive Toxicology Studies
TASK X23: Control Animal Meta-Analysis for Ebola and Other Filoviruses
国内基金
海外基金
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data